Effect of ad libitum intake of an electrolyte repository in horses that underwent a polo game

The objective of this study was to assess the effects of an electrolyte and energy repository on the hematologic and biochemical variables of horses after a polo game and compare them to the effects of a commercial electrolyte repository and water. Twelve healthy horses, aged 5 to 10 years, mean body weight 356.25 ± 25.6 kg and in training for polo games, were randomly divided into three groups of four animals each and received one of three treatments. Animals participated in a 7-minute polo game. At the end of the match, they were taken to individual stalls where they received treatments for spontaneous hydration for 6 hours. Treatments were Hydroelectrolytic and Energy Repository (RHE) containing sodium, chloride, potassium, calcium, magnesium, dextrose, maltodextrin and, sucrose; and Commercial Paste (PCO) containing calcium, fructooligosaccharides, glycine, magnesium, potassium, sodium, and ad libitum water. The control group (Water) received water. Blood samples were collected as follows: just before the beginning of exercise (T0), immediately after exercise (T1), 3 hours after the end of exercise (T3), and 6 hours after the end of exercise (T6). The volume of voluntary intake was measured at T3 and T6. Packed cell volume and serum concentrations of sodium, potassium, chloride, calcium, magnesium, phosphorus, creatinine, total protein, plasma glucose, and lactate were measured. Data were submitted to descriptive statistics (mean ± standard deviation), Lilliefors and Cochran & Bartlett tests, analysis of variance (ANOVA), and Tukey or Duncan tests at a 5% significance level. The net volume ingested by the RHE group was higher than the PCO and control groups. In all groups, a reduction in chloride concentration and increases in packed cell volume, protein, creatinine, glucose, and lactate concentrations were observed in T1. These variables returned to the values found at T0 throughout the rehydration phase (T3 and T6). It is concluded that the ingestion of the hydroelectrolytic energy repository does not cause alteration in the biochemical profile of the animals

Comparison of pupil diameter and tear production in dogs treated with acepromazine, tramadol and their combination

Some ophthalmic surgeries require induction of mydriasis, however, drugs traditionally used for this purpose significantly reduces tear production. To evaluate the effect of acepromazine and tramadol, used alone or in combination, on pupil diameter, tear production, heart and respiratory rate, systolic blood pressure and rectal temperature, these drugs were administered to seven clinically normal dogs divided into three experimental groups (G1 - acepromazine; G2 - tramadol; G3 - tramadol + acepromazine) that differed only in the sedation protocol. Parameters were measured in four experimental moments. Miosis occurred in G1, in addition to reduced tear production and respiratory rate. No significant changes were found in the parameters assessed in G2, whereas in G3, there was decrease in tear production of the right eye, decrease in the respiratory rate and rectal temperature. Tramadol proved to be a drug suitable for pre-anesthetic procedures that require the maintenance of pupil diameter and keeps the tear production within normal parameters. However, the use of acepromazine alone or in combination with tramadol requires protection of the patient’s eye surface to prevent the occurrence of undesirable ophthalmic changes.Alguns procedimentos cirúrgicos oftálmicos requerem a obtenção de midríase, entretanto, os fármacos tradicionalmente utilizados com esta finalidade reduzem significativamente a produção lacrimal. Com o objetivo de verificar o efeito da acepromazina e do tramadol, utilizados isoladamente, ou em conjunto, sobre o diâmetro pupilar, a produção lacrimal, as frequências cardíaca e respiratória, a pressão arterial sistólica e a temperatura retal, esses fármacos foram administrados em sete cães clinicamente normais, que integraram três grupos experimentais (G1 – acepromazina; G2 – tramadol; G3 – acepromazina + tramadol), diferenciando-se apenas quanto ao protocolo tranquilizante utilizado. Os parâmetros foram mensurados em quatro momentos experimentais. Houve miose no G1, além da redução da produção lacrimal e da frequência respiratória. Verificou-se que, no G2, não houve alterações significativas nos parâmetros avaliados e, no G3, verificou-se a diminuição da produção lacrimal do olho direito, da frequência respiratória e da temperatura retal. O tramadol demonstra ser um fármaco pré-anestésico adequado para procedimentos que necessitem da manutenção do diâmetro pupilar e mantém a produção lacrimal dentro dos parâmetros normais. Entretanto, com o uso da acepromazina isolada ou associada ao tramadol, torna-se necessário proteger a superfície ocular do paciente com a finalidade de se evitar a ocorrência de alterações oftálmicas indesejáveis

Comparison of pupil diameter and tear production in dogs treated with acepromazine, tramadol and their combination

Some ophthalmic surgeries require induction of mydriasis, however, drugs traditionally used for this purpose significantly reduces tear production. To evaluate the effect of acepromazine and tramadol, used alone or in combination, on pupil diameter, tear production, heart and respiratory rate, systolic blood pressure and rectal temperature, these drugs were administered to seven clinically normal dogs divided into three experimental groups (G1 - acepromazine; G2 - tramadol; G3 - tramadol + acepromazine) that differed only in the sedation protocol. Parameters were measured in four experimental moments. Miosis occurred in G1, in addition to reduced tear production and respiratory rate. No significant changes were found in the parameters assessed in G2, whereas in G3, there was decrease in tear production of the right eye, decrease in the respiratory rate and rectal temperature. Tramadol proved to be a drug suitable for pre-anesthetic procedures that require the maintenance of pupil diameter and keeps the tear production within normal parameters. However, the use of acepromazine alone or in combination with tramadol requires protection of the patient's eye surface to prevent the occurrence of undesirable ophthalmic changes

Comparison of pupil diameter and tear production in dogs treated with acepromazine, tramadol and their combination Diâmetro pupilar e produção lacrimal comparados em cães tratados com acepromazina, tramadol e sua associação

Some ophthalmic surgeries require induction of mydriasis, however, drugs traditionally used for this purpose significantly reduces tear production. To evaluate the effect of acepromazine and tramadol, used alone or in combination, on pupil diameter, tear production, heart and respiratory rate, systolic blood pressure and rectal temperature, these drugs were administered to seven clinically normal dogs divided into three experimental groups (G1 - acepromazine; G2 - tramadol; G3 - tramadol + acepromazine) that differed only in the sedation protocol. Parameters were measured in four experimental moments. Miosis occurred in G1, in addition to reduced tear production and respiratory rate. No significant changes were found in the parameters assessed in G2, whereas in G3, there was decrease in tear production of the right eye, decrease in the respiratory rate and rectal temperature. Tramadol proved to be a drug suitable for pre-anesthetic procedures that require the maintenance of pupil diameter and keeps the tear production within normal parameters. However, the use of acepromazine alone or in combination with tramadol requires protection of the patient's eye surface to prevent the occurrence of undesirable ophthalmic changes.Alguns procedimentos cirúrgicos oftálmicos requerem a obtenção de midríase, entretanto, os fármacos tradicionalmente utilizados com esta finalidade reduzem significativamente a produção lacrimal. Com o objetivo de verificar o efeito da acepromazina e do tramadol, utilizados isoladamente, ou em conjunto, sobre o diâmetro pupilar, a produção lacrimal, as frequências cardíaca e respiratória, a pressão arterial sistólica e a temperatura retal, esses fármacos foram administrados em sete cães clinicamente normais, que integraram três grupos experimentais (G1 - acepromazina; G2 - tramadol; G3 - acepromazina + tramadol), diferenciando-se apenas quanto ao protocolo tranquilizante utilizado. Os parâmetros foram mensurados em quatro momentos experimentais. Houve miose no G1, além da redução da produção lacrimal e da frequência respiratória. Verificou-se que, no G2, não houve alterações significativas nos parâmetros avaliados e, no G3, verificou-se a diminuição da produção lacrimal do olho direito, da frequência respiratória e da temperatura retal. O tramadol demonstra ser um fármaco pré-anestésico adequado para procedimentos que necessitem da manutenção do diâmetro pupilar e mantém a produção lacrimal dentro dos parâmetros normais. Entretanto, com o uso da acepromazina isolada ou associada ao tramadol, torna-se necessário proteger a superfície ocular do paciente com a finalidade de se evitar a ocorrência de alterações oftálmicas indesejáveis

Enteral electrolyte solutions with different osmolarities administered in a continuous flow in newborn calves

This study compared the effects of enteral electrolyte solutions with different osmolarities in Holstein cattle. Eighteen newborn calves were evenly divided into three groups and administered the following treatments: hypotonic electrolyte solution (ESHYPO) containing 4g NaCl, 0.5g KCl, 1g sodium acetate, and 7.5g dextrose diluted in 1,000mL water; isotonic electrolyte solution (ESISO) containing 5g NaCl, 1g KCl, 2g sodium acetate, and 10g dextrose diluted in 1,000mL water; and hypertonic electrolyte solution (ESHYPER) containing 6g NaCl, 1g KCl, 3g sodium acetate, and 15g dextrose diluted in 1,000mL water. Solutions were administered at a rate of 15mL kg –1 hr –1 for 12 hours in a continuous flow. All three solutions increased the concentration of plasma sodium, but ESHYPO did not alter the serum osmolarity. Both ESISO and ESHYPO resulted in an increase in volemia.O presente estudo comparou os efeitos de soluções de eletrolíticas enterais com diferentes osmolaridades administradas em fluxo contínuo. Dezoito animais foram divididos em três grupos: Solução eletrolítica hipotônica (SEHIPO) contendo 4g de NaCl; 0,5g de KCl; 1g de acetato de sódio; 7,5g de dextrose diluídos em 1.000mL de água; Solução eletrolítica isotônica (SEISO) contendo 5g de NaCl; 1g de KCl; 2g de acetato de sódio; 10g de dextrose diluídos em 1.000mL de água; A solução eletrolítica hipertônica (SEHIPER) contendo 6g de NaCl; 1g de KCl; 3g de acetato de sódio; 15g de dextrose diluídos em 1.000mL de água. As soluções foram administradas na dose de 15mLkg -1 26h -1 durante 12 horas. Os tratamentos SEHIPO, SEISO e SEHIPER aumentaram a concentração plasmática de sódio, contudo apenas a SEHIPO não ocasionou alteração na osmolaridade sérica. As SEHIPO e SEISO aumentaram a volemia